​

BridgeBio Pharma Ownership | Who Owns BridgeBio Pharma?

OverviewForecastRevenueFinancialsChartTranscripts

BridgeBio Pharma Ownership Summary

BridgeBio Pharma is owned by 17.14% institutional investors, 4.71% insiders, and 78.15% retail investors. Vanguard group is the largest institutional shareholder, holding 8.85% of BBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.81% of its assets in BridgeBio Pharma shares.

BBIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBridgeBio Pharma17.14%4.71%78.15%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group16.86M8.85%$1.29B
Viking global investors lp15.98M8.39%$829.89M
Blackrock funding, inc. /de14.55M7.64%$1.11B
Kohlberg kravis roberts13.26M6.96%$688.77M
Blackrock12.45M6.64%$315.31M
Farallon capital management8.19M4.30%$425.49M
State street5.61M2.94%$291.19M
Aisling capital management lp5.09M2.67%$389.30M
Janus henderson group4.91M2.60%$134.67M
Geode capital management4.41M2.32%$344.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aisling capital management lp5.09M81.29%$389.30M
Kohlberg kravis roberts13.26M11.54%$688.77M
Boone capital management460.28K7.84%$23.91M
Cutter capital management, lp560.34K6.30%$15.38M
Frazier life sciences management3.85M5.98%$199.73M
Catalio capital management, lp622.73K5.98%$32.34M
Cormorant asset management, lp1.40M5.02%$72.72M
First turn management589.73K4.60%$30.63M
Superstring capital management lp88.66K4.54%$4.60M
Eagle health investments lp259.30K4.36%$19.83M

Top Buyers

HolderShares% AssetsChange
Blackrock12.45M0.01%1.98M
Norges bank1.53M0.01%1.53M
Hood river capital management1.24M0.76%1.24M
Invesco3.93M0.03%1.13M
T. rowe price investment management1.05M0.03%1.05M

Top Sellers

HolderShares% AssetsChange
Viking global investors lp15.98M2.16%-2.58M
Macquarie group---1.93M
Woodline partners lp198.32K0.05%-1.51M
Perceptive advisors---1.22M
Hhlr advisors---1.02M

New Positions

HolderShares% AssetsChangeValue
Norges bank1.53M0.01%1.53M$116.80M
Hood river capital management1.24M0.76%1.24M$64.59M
T. rowe price investment management1.05M0.03%1.05M$54.63M
Polar capital981.06K0.25%981.06K$50.96M
Boone capital management460.28K7.84%460.28K$23.91M

Sold Out

HolderChange
Tortoise investment management-1.00
Weiss asset management lp-1.00
Financial gravity asset management-3.00
Creekmur asset management-3.00
Twin peaks wealth advisors-6.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025140-67.21%32,651,635-82.36%170.18%86-61.78%32-76.30%
Sep 30, 2025144-63.36%28,301,584-85.01%140.15%78-65.64%46-57.80%
Jun 30, 202539213.29%188,775,9601.99%991.05%22614.14%10932.93%
Mar 31, 202534412.05%185,144,5074.79%971.11%19624.05%825.13%
Dec 31, 20243048.57%172,882,4320.83%911.11%1556.90%781.30%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv5.44M2.81%13.00K
Vanguard US Total Market Shares ETF4.53M2.38%3.92K
Vanguard Small Cap Index3.93M2.03%-563.00
iShares Russell 2000 ETF3.82M1.97%1.53M
SPDR® S&P Biotech ETF2.40M1.26%5.36K
Vanguard Small Cap Growth Index Inv2.18M1.13%-36.42K
American Funds SMALLCAP World A2.07M1.09%-596.87K
Vanguard Institutional Extnd Mkt Idx Tr1.83M0.94%3.54K
American Funds New Economy A1.56M0.82%-
Capital Group New Economy Comp1.56M0.82%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 26, 2026Apuli Maricel Chief Accounting OfficerSell$132.00K
Feb 19, 2026Kumar Neil Chief Executive OfficerSell$43.83K
Feb 19, 2026Kumar Neil Chief Executive OfficerSell$1.34M
Feb 19, 2026Kumar Neil Chief Executive OfficerSell$614.70K
Feb 17, 2026Apuli Maricel Chief Accounting OfficerSell$37.90K

Insider Transactions Trends

DateBuySell
2026 Q1-36
2025 Q4-50
2025 Q3-35
2025 Q2-16
2025 Q1-15

BBIO Ownership FAQ

Who Owns BridgeBio Pharma?

BridgeBio Pharma shareholders are primarily institutional investors at 17.14%, followed by 4.71% insiders and 78.15% retail investors. The average institutional ownership in BridgeBio Pharma's industry, Biotech Stocks , is 382.11%, which BridgeBio Pharma falls below.

Who owns the most shares of BridgeBio Pharma?

BridgeBio Pharma’s largest shareholders are Vanguard group (16.86M shares, 8.85%), Viking global investors lp (15.98M shares, 8.39%), and Blackrock funding, inc. /de (14.55M shares, 7.64%). Together, they hold 24.87% of BridgeBio Pharma’s total shares outstanding.

Does Blackrock own BridgeBio Pharma?

Yes, BlackRock owns 6.64% of BridgeBio Pharma, totaling 12.45M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 315.31M$. In the last quarter, BlackRock increased its holdings by 1.98M shares, a 18.93% change.

Who is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested, with 81.29% of its assets in 5.09M BridgeBio Pharma shares, valued at 389.3M$.

Who is the top mutual fund holder of BridgeBio Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of BridgeBio Pharma shares, with 2.81% of its total shares outstanding invested in 5.44M BridgeBio Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools